World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
66
Citations
15500
World Ranking
8677
National Ranking
3893

Jerry M. Collins publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Jerry M. Collins sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 251 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Jerry M. Collins D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Jerry M. Collins sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 66 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Jerry M. Collins is affiliated with the National Institutes of Health in the United States. Their research focuses primarily on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with particular specialization in Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Genetics, and Computational Theory and Mathematics.

The scientist's work addresses multiple topics in cancer research including HER2/EGFR in Cancer Research, Computational Drug Discovery Methods, Cancer therapeutics and mechanisms, Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology, Epigenetics and DNA Methylation, and Lung Cancer Treatments and Mutations.

Key recent publications by Jerry M. Collins include:

  • Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based Resource (2023), Molecular Cancer Therapeutics
  • Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomas (2020), Oncotarget
  • F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd (2021), Molecular Cancer Therapeutics
  • Phase 1 study of Z-Endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors (2021), Oncotarget
  • Abstract PD7-06: A randomized phase II trial of tamoxifen versus Z-endoxifen HCL in postmenopausal women with metastatic estrogen receptor positive, HER2 negative breast cancer (2020), Cancer Research

Jerry M. Collins has frequently published in venues such as:

  • Cancer Research
  • Journal of Clinical Oncology
  • Molecular Cancer Therapeutics
  • Oncotarget
  • Clinical Cancer Research

Frequent collaborators in their research include James H. Doroshow, Geraldine O'Sullivan Coyne, Shivaani Kummar, Richard Piekarz, and Larry Rubinstein. These coauthors have partnered with Collins across multiple projects and publications.

Best Publications

  • ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX

    Robert Yarchoan;Kent J. Weinhold;H. Kim Lyerly;Edward Gelmann

  • Accelerated Titration Designs for Phase I Clinical Trials in Oncology

    Richard Simon;Boris Freidlin;Larry Rubinstein;Susan G. Arbuck

  • PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)

    Robert Yarchoan;Rose V. Thomas;Jean Pierre Allain;Nanette Mcatee

  • Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases.

    Raymond W Klecker;Jerry M Collins;Robert Yarchoan;Rose Thomas

  • Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development

    Carl C. Peck;William H. Barr;Leslie Z. Benet;Jerry Collins

  • Cancer Chemotherapy: Principles and Practice

    Bruce Chabner;Jerry M. Collins

  • Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies

    Shivaani Kummar;Robert Kinders;Martin E. Gutierrez;Larry Rubinstein

  • Plasma Pharmacokinetics of Adriamycin and Adriamycinol: Implications for the Design of in Vitro Experiments and Treatment Protocols

    Raymond F. Greene;Jerry M. Collins;Jean F. Jenkins;James L. Speyer

  • Analysis of Food and Drug Administration–Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines

    Susan L. Holbeck;Jerry M. Collins;James H. Doroshow

  • Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered

    Solomon Zimm;Jerry M. Collins;Riccardo Riccardi;Dondra O'Neill

  • Phase I and Pharmacological Studies of 5-Fluorouracil Administered Intraperitoneally

    James L. Speyer;Jerry M. Collins;Robert L. Dedrick;Murray F. Brennan

  • Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.

    Anthony Elias;Louise Ryan;Aaron Sulkes;Jerry Collins

  • Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism.

    Michael E. Fitzsimmons;Jerry M. Collins

  • Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors

    Khanh Do;Deborah Wilsker;Jiuping Ji;Jennifer Zlott

  • The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity

    Susan L. Holbeck;Richard Camalier;James A Crowell;Jeevan Prasaad Govindharajulu

  • Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements

    Shivanni Kummar;Helen X. Chen;John Wright;Susan Holbeck

  • Portal Levels and Hepatic Clearance of 5-Fluorouracil after Intraperitoneal Administration in Humans

    James L. Speyer;Paul H. Sugarbaker;Jerry M. Collins;Robert L. Dedrick

  • Potential roles for preclinical pharmacology in phase I clinical trials.

    J M Collins;D S Zaharko;R L Dedrick;B A Chabner

  • Pharmacologically Guided Phase I Clinical Trials Based Upon Preclinical Drug Development

    Jerry M. Collins;Charles K. Grieshaber;Bruce A. Chabner

  • Chemosensitivity Testing of Human Colorectal Carcinoma Cell Lines Using a Tetrazolium-based Colorimetric Assay

    Jae-Gahb Park;Barnett S. Kramer;Seth M. Steinberg;James Carmichael

Frequent Co-Authors

James H. Doroshow
James H. Doroshow National Institutes of Health
Timothy J. Kinsella
Timothy J. Kinsella Brown University
Charles E. Myers
Charles E. Myers University of Virginia
David G. Poplack
David G. Poplack Baylor College of Medicine
Seth M. Steinberg
Seth M. Steinberg National Institutes of Health
Otto Muzik
Otto Muzik Wayne State University
Bruce A. Chabner
Bruce A. Chabner Harvard University
Robert H. Wiltrout
Robert H. Wiltrout National Institutes of Health
Leslie Z. Benet
Leslie Z. Benet University of California, San Francisco
Samuel Broder
Samuel Broder Precision BioSciences

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry can open the door to a diverse array of careers in healthcare, diagnostics, and nutrition. Today, many students are choosing flexible online programs to advance their education and job prospects in these fields.

For those drawn to data, managing health records is a vital part of modern medicine. Earning a him degree online prepares graduates for in-demand roles in hospitals and clinics. If nutrition and wellness are your passion, consider enrolling in the cheapest online nutrition degree programs to gain specialized knowledge and skills.

Diagnostic careers are also popular among Biology and Biochemistry graduates. High-quality online sonography programs teach students how to use medical imaging to support patient care. If radiologic technology interests you, finding the cheapest radiology tech programs can help you enter the workforce quickly and affordably.

Exploring these online degree pathways can complement or expand your expertise in Biology and Biochemistry and help you build a rewarding healthcare career.

Best Scientists Citing Jerry M. Collins

Trending Scientists

Recently Published Articles